Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ethanol + nicotine refers to the concurrent use or co-administration of two psychoactive substances—ethanol (commonly known as alcohol) and nicotine. Both are among the most widely used drugs globally, often co-used in both acute (bingeing/chipping) and chronic patterns. The combination is notable for its unique neurobehavioral effects that differ from either substance alone. Preclinical studies show that combined exposure can produce age-dependent changes in brain function and behavior, such as increased locomotion and reduced anxiety in adolescent animals but not adults[1]. In humans, ethanol potentiates some of the rewarding effects of nicotine—including smoking satisfaction, stimulant/calming sensations, and craving relief—suggesting a synergistic interaction on neural reward pathways[2][6]. The combination can also alter impulsive choice behaviors more than either drug alone[5], with evidence for both synergistic (augmented reinforcement/anxiolysis at low doses) and antagonistic interactions depending on dose ratios[6][5]. Mechanistically, both drugs act on overlapping neural circuits involving dopaminergic signaling; ethanol may enhance or modulate nicotinic acetylcholine receptor activity while also affecting GABAergic/glutamatergic transmission. This dual action likely underlies their high rates of co-use/dependence observed clinically.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ethanol + nicotine.